|
C20ORF94 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.345590E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.732390E-02 |
| Normal-vs-Stage2 |
9.038800E-01 |
| Normal-vs-Stage3 |
6.558200E-01 |
| Normal-vs-Stage4 |
9.563900E-02 |
| Stage1-vs-Stage2 |
4.099800E-01 |
| Stage1-vs-Stage3 |
4.374200E-01 |
| Stage1-vs-Stage4 |
7.969200E-01 |
| Stage2-vs-Stage3 |
8.458400E-01 |
| Stage2-vs-Stage4 |
4.691200E-01 |
| Stage3-vs-Stage4 |
5.184800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.457000E-01 |
| Normal-vs-AfricanAmerican |
5.729600E-02 |
| Normal-vs-Asian |
3.138600E-03 |
| Caucasian-vs-AfricanAmerican |
3.423600E-01 |
| Caucasian-vs-Asian |
3.427500E-04 |
| AfricanAmerican-vs-Asian |
9.496100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.537960E-02 |
| Normal-vs-Female |
4.030000E-01 |
| Male-vs-Female |
8.103800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.776200E-02 |
| Normal-vs-Extreme_Weight |
6.622800E-04 |
| Normal-vs-Obese |
8.466000E-01 |
| Normal-vs-Extreme_Obese |
3.585200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.178200E-01 |
| Normal_Weight-vs-Obese |
1.019970E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.335800E-01 |
| Extreme_Weight-vs-Obese |
3.458800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.838000E-01 |
| Obese-vs-Extreme_Obese |
3.920600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.651400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.642200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.853550E-02 |
| Normal-vs-Age(81-100Yrs) |
1.789870E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.806200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.010800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.027700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.138200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.022000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.425800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.782200E-02 |
| Normal-VS-Type2 PRCC |
7.041100E-03 |
| Normal-VS-KIRP CIMP |
5.788800E-01 |
| Normal-VS-Unclassified PRCC |
1.581400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.255600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.485630E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.391700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.241600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.459300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.628800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.466000E-02 |
| Normal-vs-N1 |
8.300200E-01 |
| Normal-vs-N2 |
4.867400E-01 |
| N0-vs-N1 |
2.025800E-01 |
| N0-vs-N2 |
7.627600E-01 |
| N1-vs-N2 |
7.588800E-01 |
|
|
